LIMNW — Liminatus Pharma, Inc. Warrants
Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.
Company profile
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
- Exchange: NASDAQ
- Website: https://liminatuspharma.com
Latest SEC filings for LIMNW
- S-1 — 2026-06-24
- 8-K — 2026-02-09
Educational tool only — not investment advice.